Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kiberd BA et al. - Immunosuppression is associated with an increased risk of cancer in kidney transplant recipients compared to the general population. It is less clear whether standardized cancer mortality ratios (SMRs) are also increased. The findings challenge the notion that cancer is a major cause of premature death in all kidney transplant recipients and has implications for design of cancer prevention strategies in kidney transplant recipients.


Today in Nephrology/Urology...keeping you current

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/23/09

Mycophenolate Mofetil Reduces Late Renal Allograft Loss Independent of Acute Rejection
Transplantation, 10/29/09

T Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective
Clinical Cancer Research, 10/26/09

Today in Surgery/Transplantation...keeping you current

Antibody-mediated rejection following transplantation from an HLA-identical sibling
Nephrology Dialysis Transplantation, 10/30/09

Mycophenolate Mofetil Reduces Late Renal Allograft Loss Independent of Acute Rejection
Transplantation, 10/29/09

ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address